209 related articles for article (PubMed ID: 3458722)
1. McArdle's disease heterozygotes. Metabolic adaptation assessed using 31P-nuclear magnetic resonance.
Bogusky RT; Taylor RG; Anderson LJ; Angelos KL; Lieberman JS; Walsh DA
J Clin Invest; 1986 Jun; 77(6):1881-7. PubMed ID: 3458722
[TBL] [Abstract][Full Text] [Related]
2. McArdle's disease in two generations: autosomal recessive transmission with manifesting heterozygote.
Schmidt B; Servidei S; Gabbai AA; Silva AC; de Sousa Bulle de Oliveira A; DiMauro S
Neurology; 1987 Sep; 37(9):1558-61. PubMed ID: 3476861
[TBL] [Abstract][Full Text] [Related]
3. Breakdown of adenine nucleotide pool in fatiguing skeletal muscle in McArdle's disease: a noninvasive 31P-MRS and EMG study.
Zange J; Grehl T; Disselhorst-Klug C; Rau G; Müller K; Schröder R; Tegenthoff M; Malin JP; Vorgerd M
Muscle Nerve; 2003 Jun; 27(6):728-36. PubMed ID: 12766985
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). RNA and DNA analysis.
Gautron S; Daegelen D; Mennecier F; Dubocq D; Kahn A; Dreyfus JC
J Clin Invest; 1987 Jan; 79(1):275-81. PubMed ID: 3466902
[TBL] [Abstract][Full Text] [Related]
5. Examination of a case of suspected McArdle's syndrome by 31P nuclear magnetic resonance.
Ross BD; Radda GK; Gadian DG; Rocker G; Esiri M; Falconer-Smith J
N Engl J Med; 1981 May; 304(22):1338-42. PubMed ID: 6938778
[No Abstract] [Full Text] [Related]
6. Glucose infusion abolishes the excessive ATP degradation in working muscles of a patient with McArdle's disease.
Mineo I; Kono N; Yamada Y; Hara N; Kiyokawa H; Hamaguchi T; Kawachi M; Yamasaki T; Nakajima H; Kuwajima M
Muscle Nerve; 1990 Jul; 13(7):618-20. PubMed ID: 2388661
[TBL] [Abstract][Full Text] [Related]
7. Absence of functional messenger RNA for glycogen phosphorylase in the muscle of two patients with McArdle's disease.
Daegelen D; Munnich A; Levin MJ; Girault A; Goasguen J; Kahn A; Dreyfus JC
Ann Hum Genet; 1983 May; 47(2):107-15. PubMed ID: 6576726
[TBL] [Abstract][Full Text] [Related]
8. [McArdle's disease. Apropos of a case].
Yuste JR; Beloqui O; De la Peña A; Rodríguez-Rosado R; Monreal JI; Prósper F; Prieto J
Rev Med Univ Navarra; 1998; 42(1):29-33. PubMed ID: 10420954
[TBL] [Abstract][Full Text] [Related]
9. Manifesting heterozygotes in McArdle's disease: clinical, morphological and biochemical studies in a family.
Manfredi G; Silvestri G; Servidei S; Ricci E; Mirabella M; Bertini E; Papacci M; Rana M; Tonali P
J Neurol Sci; 1993 Mar; 115(1):91-4. PubMed ID: 8468596
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of branched-chain amino acids and ammonia during exercise: clues from McArdle's disease.
Wagenmakers AJ; Coakley JH; Edwards RH
Int J Sports Med; 1990 May; 11 Suppl 2():S101-13. PubMed ID: 2193889
[TBL] [Abstract][Full Text] [Related]
11. [McArdle's disease without typical symptoms].
Watanabe M; Matsubara E; Amari M; Okamoto K; Hirai S
Rinsho Shinkeigaku; 1990 Nov; 30(11):1247-51. PubMed ID: 2085931
[TBL] [Abstract][Full Text] [Related]
12. McArdle's disease: biochemical and molecular genetic studies.
Servidei S; Shanske S; Zeviani M; Lebo R; Fletterick R; DiMauro S
Ann Neurol; 1988 Dec; 24(6):774-81. PubMed ID: 3207360
[TBL] [Abstract][Full Text] [Related]
13. McArdle's disease in an elderly woman.
Harris RA; Dowben RM
South Med J; 1985 Feb; 78(2):191-3. PubMed ID: 3856326
[TBL] [Abstract][Full Text] [Related]
14. McArdle's disease: molecular genetics and metabolic consequences of the phenotype.
Beynon RJ; Bartram C; Hopkins P; Toescu V; Gibson H; Phoenix J; Edwards RH
Muscle Nerve Suppl; 1995; 3():S18-22. PubMed ID: 7603521
[TBL] [Abstract][Full Text] [Related]
15. Impairment of the exercise-induced increase in muscle perfusion in McArdle's disease.
Jehenson P; Leroy-Willig A; de Kerviler E; Merlet P; Duboc D; Syrota A
Eur J Nucl Med; 1995 Nov; 22(11):1256-60. PubMed ID: 8575473
[TBL] [Abstract][Full Text] [Related]
16. Impairment of sympathetic activation during static exercise in patients with muscle phosphorylase deficiency (McArdle's disease).
Pryor SL; Lewis SF; Haller RG; Bertocci LA; Victor RG
J Clin Invest; 1990 May; 85(5):1444-9. PubMed ID: 2332499
[TBL] [Abstract][Full Text] [Related]
17. Myophosphorylase deficiency (McArdle's disease): report of a family.
Mahmud MZ; Howell RR; Stevenson RE; Gilroy J
Can J Neurol Sci; 1976 Aug; 3(3):175-9. PubMed ID: 1067141
[TBL] [Abstract][Full Text] [Related]
18. Muscle energy metabolism in McArdle's syndrome by in vivo phosphorus magnetic resonance spectroscopy.
Argov Z; Bank WJ; Maris J; Chance B
Neurology; 1987 Nov; 37(11):1720-4. PubMed ID: 3478608
[TBL] [Abstract][Full Text] [Related]
19. Low muscle levels of pyridoxine in McArdle's syndrome.
Haller RG; Dempsey WB; Feit H; Cook JD; Knochel JP
Am J Med; 1983 Feb; 74(2):217-20. PubMed ID: 6572033
[TBL] [Abstract][Full Text] [Related]
20. [Clinical features, diagnosis and treatment of McArdle's glycogenosis].
Lobzin VS; Saĭkova LA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):342-5. PubMed ID: 6586038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
